Overview
Medtronic plc Financial Statements FY2023-FY2027Q1
Medtronic's income statement and balance sheet, FY2023 through FY2027Q1, as a public, auditable plain-text Beancount ledger — reconstructed line by line from the company's own Form 10-K and 10-Q filings and version-controlled in git. Par… Ledger notes
Financial position
Net worth and the accounts that make it up
Money movement
Monthly income and spending by account category
Recent activity
Posting-aware activity from the journal
Income vs Expenses
Period data
| Period | Income | Expenses | Net Profit |
|---|---|---|---|
| 2023-04-30 | 31,227 MUSD | 27,469 MUSD | 3,758 MUSD |
| 2023-05-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2023-06-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2023-07-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2023-08-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2023-09-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2023-10-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2023-11-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2023-12-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-01-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-02-29 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-03-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-04-30 | 32,364 MUSD | 28,688 MUSD | 3,676 MUSD |
| 2024-05-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-06-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-07-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-08-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-09-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-10-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-11-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2024-12-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-01-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-02-28 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-03-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-04-30 | 33,537 MUSD | 28,875 MUSD | 4,662 MUSD |
| 2025-05-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-06-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-07-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-08-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-09-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-10-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-11-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2025-12-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2026-01-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2026-02-28 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2026-03-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2026-04-30 | 36,364 MUSD | 31,563 MUSD | 4,801 MUSD |
| 2026-05-31 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2026-06-30 | -0 MUSD | 0 MUSD | -0 MUSD |
| 2026-07-31 | 9,756 MUSD | 8,286 MUSD | 1,470 MUSD |
Balance Sheet
Breakdown
| Account | Amount | Share of total |
|---|---|---|
| Assets:NonCurrent:PropertyPlantEquipment | 7,473 MUSD | 8.01% |
| Assets:NonCurrent:Other | 8,018 MUSD | 8.59% |
| Assets:NonCurrent:IntangibleAssets | 10,238 MUSD | 10.97% |
| Assets:NonCurrent:Goodwill | 43,187 MUSD | 46.29% |
| Assets:Current:ShortTermInvestments | 7,128 MUSD | 7.64% |
| Assets:Current:Other | 2,999 MUSD | 3.21% |
| Assets:Current:Inventories | 6,215 MUSD | 6.66% |
| Assets:Current:Cash | 1,691 MUSD | 1.81% |
| Assets:Current:AccountsReceivable | 6,357 MUSD | 6.81% |
Breakdown
| Account | Amount | Share of total |
|---|---|---|
| Liabilities:NonCurrent:Other | 5,040 MUSD | 11.87% |
| Liabilities:NonCurrent:LongTermDebt | 25,617 MUSD | 60.34% |
| Liabilities:Current:ShortTermDebt | 2,536 MUSD | 5.97% |
| Liabilities:Current:Other | 6,568 MUSD | 15.47% |
| Liabilities:Current:AccountsPayable | 2,695 MUSD | 6.35% |
Cash Flow
Loading account roles…
Medtronic plc (MDT) Financial Statements in Beancount — Open Ledger
Medtronic's income statement and balance sheet, FY2023 through FY2027Q1, as a public, auditable plain-text Beancount ledger — reconstructed line by line from the company's own Form 10-K and 10-Q filings and version-controlled in git. Part of the Open Ledger project on beancount.io.
Browse it live: beancount.io/ledger/open_ledger/medtronic
Latest analysis: Medtronic FY2027 Q1 Earnings: $9.76B Revenue, a 53-Week Calendar, and Cardiac Ablation at +88%
Key Figures
| Period | Period end | Revenue | Net income |
|---|---|---|---|
| FY2023 | 2023-04-28 | 31,227 | 3,758 |
| FY2024 | 2024-04-26 | 32,364 | 3,676 |
| FY2025 | 2025-04-25 | 33,537 | 4,662 |
| FY2026 | 2026-04-24 | 36,364 | 4,801 |
| FY2027Q1 | 2026-07-31 | 9,756 | 1,470 |
Amounts in MUSD (millions of US dollars), exactly as the ledger records them.
What's Inside
| Period | File | Source |
|---|---|---|
| FY2023 | FY2023/FY2023.bean | FY2023 10-K; companyfacts CIK0001613103 |
| FY2024 | FY2024/FY2024.bean | FY2024 10-K; companyfacts CIK0001613103 |
| FY2025 | FY2025/FY2025.bean | FY2025 10-K; companyfacts CIK0001613103 |
| FY2026 | FY2026/FY2026.bean | FY2026 10-K and comparative BS in Q1 FY27 10-Q 0001628280-26-060473 |
| FY2027Q1 | FY2027/FY2027Q1.bean | 10-Q accn 0001628280-26-060473 |
Fiscal years end on the last Friday of April (SEC CIK 0001613103); FY2027 is a 53-week year, and FY2027Q1 is its 14-week quarter ended July 31, 2026. FY2023–FY2026 come from Form 10-K filings and FY2027Q1 from the first-quarter earnings release and Form 10-Q. The filing totals in each banner state equity including noncontrolling interests; inventories are carried in Assets:Current:Inventories.
Quick Start
uvx --from beancount bean-check main.bean
uvx --from beanquery bean-query main.bean \
"SELECT year, sum(position) WHERE account ~ '^Income:Revenue' GROUP BY year ORDER BY year"Zero output from bean-check means the ledger is internally consistent: every
income statement sums to zero and every balance-sheet snapshot reconciles to
the filed totals. The query prints revenue by calendar year; income is a
credit, so it shows as a negative number. Open main.bean in Fava
or import it into beancount.io to explore it visually.
Methodology
- Balance sheet —
pad/balancedirectives assert each period-end
figure against the filing named in that period file's source banner. - Income statement — one zero-sum transaction per period:
Income
negative (credit),Expensespositive (debit), with the arithmetic check in
a comment directly above it. - Unit —
MUSD;9,756 MUSDmeans 9,756 million US dollars. - Additional accounts —
Assets:Current:Inventories, opened beyond the
standard chart (see each account'sopenline inmain.bean).
Analysis
- Medtronic FY2027 Q1 Earnings: $9.76B Revenue, a 53-Week Calendar, and Cardiac Ablation at +88% — FY2027Q1
Corrections
Found a figure that does not match the filing? Email
[email protected] with the period, the account
and the filing page. Corrections are committed with the source cited.
About Open Ledger
Open Ledger is a growing library of public-company financial statements
published as plain-text accounting at
beancount.io/ledger — git-versioned, diffable
across companies, and auditable against primary filings. Read the analysis
behind the numbers on the beancount.io blog.
Disclaimer
This ledger is an independent reconstruction of Medtronic plc's publicly filed
financial statements, provided for educational and informational purposes
only. It is not investment, financial, legal, tax, or accounting advice, and
is not an offer or recommendation to buy or sell any security. Beancount.io is
not affiliated with, endorsed by, or sponsored by Medtronic plc; all trademarks
belong to their respective owners. Figures may contain errors, omissions, or
simplifications and may lag the latest filings — the company's own regulatory
filings are the authoritative source. Provided "as is" without warranty of any
kind; use at your own risk.